Greenrose Acquisition Corp Stock EBITDA
Greenrose Acquisition Corp fundamentals help investors to digest information that contributes to Greenrose Acquisition's financial success or failures. It also enables traders to predict the movement of Greenrose OTC Stock. The fundamental analysis module provides a way to measure Greenrose Acquisition's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Greenrose Acquisition otc stock.
Greenrose |
Greenrose Acquisition Corp OTC Stock EBITDA Analysis
Greenrose Acquisition's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Greenrose Acquisition EBITDA | (11.53 M) |
Most of Greenrose Acquisition's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Greenrose Acquisition Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Greenrose Acquisition Corp reported earnings before interest,tax, depreciation and amortization of (11.53 Million). This is 101.31% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The ebitda for all United States stocks is 100.3% higher than that of the company.
Greenrose EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Greenrose Acquisition's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Greenrose Acquisition could also be used in its relative valuation, which is a method of valuing Greenrose Acquisition by comparing valuation metrics of similar companies.Greenrose Acquisition is currently under evaluation in ebitda category among its peers.
Greenrose Fundamentals
| Return On Equity | 0.35 | |||
| Return On Asset | -0.15 | |||
| Profit Margin | 0.47 % | |||
| Operating Margin | (1.46) % | |||
| Current Valuation | 147.92 M | |||
| Shares Outstanding | 17.68 M | |||
| Shares Owned By Insiders | 71.75 % | |||
| Shares Owned By Institutions | 15.15 % | |||
| Number Of Shares Shorted | 290.74 K | |||
| Price To Earning | 0.57 X | |||
| Price To Book | 0.48 X | |||
| Price To Sales | 0.25 X | |||
| Revenue | 28.4 M | |||
| Gross Profit | 18.68 M | |||
| EBITDA | (11.53 M) | |||
| Net Income | 83.3 M | |||
| Cash And Equivalents | 1.61 M | |||
| Cash Per Share | 0.09 X | |||
| Total Debt | 119.81 M | |||
| Debt To Equity | 2.38 % | |||
| Current Ratio | 0.15 X | |||
| Book Value Per Share | 0.82 X | |||
| Cash Flow From Operations | (47.71 M) | |||
| Short Ratio | 2.80 X | |||
| Earnings Per Share | 3.10 X | |||
| Number Of Employees | 91 | |||
| Beta | 0.32 | |||
| Market Capitalization | 12.2 M | |||
| Total Asset | 239.09 M | |||
| Net Asset | 239.09 M |
Thematic Opportunities
Explore Investment Opportunities
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Greenrose OTC Stock
If you are still planning to invest in Greenrose Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Greenrose Acquisition's history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |